Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,099 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT07070518

Conditions
Adenocarcinoma, Adult Refractory Cancer, Bronchial Neoplasms, +44 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations
  • Institut de Cancérologie de l'Ouest Angers, France
  • Institut du Cancer Avignon-Provence Avignon, France
  • CHU Jean Minjoz Besançon, France
  • CHU Morvan Brest, France
View all 22 locations
View Trial Details
Recruiting

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

NCT06964815

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • IRCCS Istituto delle Scienze Neurologiche di Bologna Bologna, BO, Italy
  • IRST Dino Amadori Meldola, FC, Italy
  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco " Catania, Italia/Catania, Italy
  • Azienda Ospedaliera Universitaria - Careggi Florence, Italia/FI, Italy
View all 16 locations
View Trial Details
Recruiting

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

NCT04681417

Conditions
Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations
  • La Reunion - Chr Felix Guyon Saint-Denis, La Réunion, France
  • Amiens Chu Amiens, France
  • Angers Chu Angers, France
  • BESANCON CHU Hopital Jean Minjoz Besançon, France
View all 28 locations
View Trial Details
Recruiting

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775

Conditions
Acute Lymphatic Leukemia, B-cell Non Hodgkin Lymphoma, Childhood Non-Hodgkin Lymphoma, +34 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Köln Cologne, Germany
  • Uniklinikum Erlangen Erlangen, Germany
  • Universitätsmedizin Göttingen Göttingen, Germany
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions
Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions